Globus Medical, Inc.
GMED
$58.74
-$0.88-1.48%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 538.68% | 1,160.31% | 76.30% | 5,093.99% | -44.97% |
| Total Depreciation and Amortization | 10.78% | 19.39% | -4.12% | 79.06% | 252.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -283.77% | -44.26% | 38.30% | 265.31% | 877.72% |
| Change in Net Operating Assets | 51.58% | 122.48% | 160.06% | 2,288.07% | -141.16% |
| Cash from Operations | 43.51% | 238.44% | 100.95% | 303.40% | 54.90% |
| Capital Expenditure | -67.50% | -26.38% | 25.22% | -94.82% | -55.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5,068.77% | -- | -- | 99.97% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 3,220.70% | -125.33% | -88.43% | -68.18% |
| Cash from Investing | -2,782.14% | 382.04% | -132.48% | 81.49% | -119.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.01% | 228.83% | 6,561.83% | 612.49% | 345.08% |
| Repurchase of Common Stock | -1,131.88% | -117.40% | 99.60% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.32% | 87.24% | -304.32% | -64.46% | -62.93% |
| Cash from Financing | -386.34% | -449.08% | 125.18% | 1,274.25% | 703.41% |
| Foreign Exchange rate Adjustments | 280.60% | 206.85% | -1,132.85% | 92.08% | 771.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -511.31% | -185.41% | -13.85% | 891.38% | -36.51% |